Crossref
Ruxolitinib in treating polycythemia vera: what is it that we do not know yet?
Onkologie · 03.05.2024 · 18 (2) · 121-124
DOI: 10.36290/xon.2024.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Onkologie, erschienen am 03.05.2024. Verfasst von Petra Bělohlávková. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bělohlávková, P. (2024). Ruxolitinib in treating polycythemia vera: what is it that we do not know yet?. Onkologie, 18(2), 121-124. https://doi.org/10.36290/xon.2024.022
Vancouver
Bělohlávková P. Ruxolitinib in treating polycythemia vera: what is it that we do not know yet?. Onkologie. 2024;18(2):121-124. doi:10.36290/xon.2024.022
BibTeX
@article{Blohlvkov2024,
author = {Bělohlávková, Petra},
title = {Ruxolitinib in treating polycythemia vera: what is it that we do not know yet?},
journal = {Onkologie},
year = {2024},
volume = {18},
number = {2},
pages = {121--124},
doi = {10.36290/xon.2024.022}
}
EUVIMED